GENEVA, May 5 -- REMEGEN CO., LTD. (No. 58 Beijing Middle Road, Yantai Development Zone, Yantai District, China (Shandong) Pilot Free Trade ZoneYantai, Shandong 264006), 荣昌生物制药(烟台)股份有限公司 (中国山东省烟台市中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号) filed a patent application (PCT/CN2024/127247) for "METHOD FOR TREATING AUTOIMMUNE ENCEPHALITIS WITH TACI-FC FUSION PROTEIN" on Oct 25, 2024. With publication no. WO/...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.